Hoda Anton-Culver

Title: Hoda Anton-Culver: Innovator in Cancer Diagnosis and Treatment

Introduction

Hoda Anton-Culver is a prominent inventor based in Irvine, CA (US). She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of colorectal cancer. With a total of 3 patents, her work has the potential to impact patient care and treatment options significantly.

Latest Patents

One of her latest patents focuses on carcinoma diagnosis and treatment based on the ODC1 genotype. This invention provides methods and kits for predicting colorectal cancer patient survival, as well as the survival of patients with other invasive cancers linked to high levels of ODC activity and increased cellular polyamine contents. The patent also outlines how to select appropriate treatment options based on the allelic nucleotide sequence or SNP at position +316 of the ODC1 promoter gene. This innovative approach aims to guide treatment selection by determining the ODC1 promoter +316 position genotype.

Career Highlights

Hoda Anton-Culver has had a distinguished career, working at esteemed institutions such as the University of Arizona and the University of California. Her research has focused on the genetic factors influencing cancer progression and treatment outcomes, making her a key figure in the field of oncology.

Collaborations

Throughout her career, Hoda has collaborated with notable colleagues, including Eugene W. Gerner and Jason A. Zell. These partnerships have furthered her research and contributed to the development of her innovative patents.

Conclusion

Hoda Anton-Culver's work in cancer diagnosis and treatment exemplifies the impact of innovation in healthcare. Her patents and research continue to pave the way for improved patient outcomes in the fight against cancer.